Folic acid improves baroreceptor sensitivity in hypertension

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 1, 2005, Pages 44-48

  Béchir, Markus ^a   Enseleit, Frank ^a   Chenevard, Rémy ^a   Muntwyler, Jörg ^a   Lüscher, Thomas F ^a   Noll, Georg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Baroreceptor function; Folic acid; Hypertension; Muscle sympathetic activity

Indexed keywords

FOLIC ACID; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART FUNCTION; HUMAN; HYPERTENSION; MALE; ORTHOSTATIC HYPERTENSION; PRESSORECEPTOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VAGUS NERVE STIMULATION; VASCULARIZATION;

ANTIOXIDANTS; FOLIC ACID; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PRESSORECEPTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 11144320493     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200501000-00008     Document Type: Article

References (23)

1. Verhaar MC, Wever RM, Kastelein JJ, et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation. 1999;100:335-338.
2. Doshi SN, McDowell IF, Moat SJ, et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 2002;105:22-26.
3. Schnyder G, Roffi M, Pin R, et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med. 2001;345: 1593-1600.
4. Lucini D, Mela GS, Malliani A, et al. Impairment in cardiac autonomic regulation preceding arterial hypertension in humans: insights from spectral analysis of beat-by-beat cardiovascular variability. Circulation. 2002;106:2673-2679.
5. Matsukawa T, Gotoh E, Miyajima E, et al. Angiotensin II inhibits baroreflex control of muscle sympathetic nerve activity and the heart rate in patients with essential hypertension. J Hypertens Suppl. 1988;6:S501-S504.
6. Grassi G, Cattaneo BM, Seravalle G, et al. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68-72.
7. Xie PL, Chapleau MW, McDowell TS, et al. Mechanism of decreased baroreceptor activity in chronic hypertensive rabbits. Role of endogenous prostanoids. J Clin Invest. 1990;86:625-630.
8. Matsuda T, Bates JN, Lewis SJ, et al. Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. Circ Res. 1995;76:426-433.
9. Li Z, Mao HZ, Abboud FM, et al. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ Res. 1996;79: 802-811.
10. Verhaar MC, Wever RM, Kastelein JJ, et al. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97:237-241.
11. Pagani P, Somers V, Furlan R, et al. Changes in autonomie regulation induced by physical training in mild hypertension. Hypertension. 1988; 12:600-610.
12. Smyth HS, Sleight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res. 1969;24:109-121.
13. Delius W, Hagbarth KE, Hongell A, et al. General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand. 1972; 84:65-81.
14. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
15. Parati G, Di Rienzo M, Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens. 2000;18: 7-19.
16. Parati G, Fratolla A, Di Rienzo M, et al. Effects of aging on 24 hour dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol. 1995;268:H1606-H1612.
17. Grassi G, Cattaneo BM, Seravalle G, et al. Baroreflex impairment by low sodium diet in mild or moderate essential hypertension. Hypertension. 1997;29:802-807.
18. Brouwer IA, van Dusseldorp M, Duran M, et al. Low-dose folic acid supplementation does not influence plasma methionine concentrations in young non-pregnant women. Br J Nutr. 1999;82:85-89.
19. Stroes ES, van Faassen EE, van Londen GJ, et al. Oxygen radical stress in vascular disease: the role of endothelial nitric oxide synthase. J Cardiovasc Pharmacol. 1998;32:S14-S21.
20. Chapleau MW, Cunningham JT, Sullivan MJ, et al. Structural versus functional modulation of the arterial baroreflex. Hypertension. 1995;26: 341-347.
21. Zhang K, Patel KP. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am J Physiol. 1998;275:R728-R734.
22. Wu D, Pardridge WM. Blood-brain barrier transport of reduced folic acid. Pharm Res. 1999;16:415-419.
23. La Rovere MT, Pinna GD, Hohnloser SH, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001; 103:2072-2077.